MRTX1133 RESISTANCE - AN OVERVIEW

The identification of KRASG12C inhibitors has reignited fascination in focusing on RAS proteins. This work describes the discovery on the KRASG12D-precise inhibitor MRTX1133 and demonstrates the feasibility of potently and selectively targeting this oncogenic variant.These findings, Dr. Luo reported, suggest that MRTX1133 will help enlist the immun